Senegal - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Senegal Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases rose 5.4% year on year. In 2019, the country was ranked number 141 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases with 91 Cases. India topped the ranking with 66,255 Cases in 2019, that is +13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia recorded the worst performance at -100% per year.
Loading...
Date | Units (Cases) |
---|---|
2019 | 91.00 |
2018 | 86.00 |
2017 | 86.00 |
2016 | 64.00 |
2015 | 78.00 |
Download all data from 2007 to 2019
How does Senegal rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
# | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
141 |
#141
Italy
|
91 | 2019 | +2.3 % | -0.4 % | View data | |
141 |
#141
Senegal
|
91 | 2019 | +5.8 % | +5.4 % | View data | |
145 |
#145
Germany
|
90 | 2014 | -19.6 % | +5.2 % | View data |